Close

Guggenheim Downgrades Alnylam Pharmaceuticals (ALNY) to Neutral

February 22, 2021 6:48 AM EST Send to a Friend
Guggenheim analyst Whitney Ljem downgraded Alnylam Pharmaceuticals (NASDAQ: ALNY) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login